GLP-1 Commitment Issues

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Amy Bucher Chief Behavioral OfficerLirio

Amy Bucher

Chief Behavioral OfficerLirio

Antoine Pivron Vice President, Health SolutionsWithings Health Solutions

Antoine Pivron

Vice President, Health SolutionsWithings Health Solutions

Christina Valentine Chief Medical OfficerKate Farms

Christina Valentine

Chief Medical OfficerKate Farms

Cody Fair Chief Commercial OfficerNoom

Cody Fair

Chief Commercial OfficerNoom

Maya Goldman Health ReporterAxios

Maya Goldman

Health ReporterAxios

About this Session:

The GLP-1 honeymoon phase doesn’t last forever. Only 8% of GLP-1 users stick with treatment after three years, serving as a reality check that breakthrough medications without proper infrastructure often fall short of their promise. The factors contributing to derailing long-term success include persistent side effects that accumulate over time, the psychological weight of lifelong medication dependency, and most critically, the glaring absence of comprehensive nutritional counseling and behavioral frameworks that are necessary for sustained results. Enter the tech cavalry. AI-powered behavioral interventions are evolving far beyond basic medication reminders, while predictive analytics platforms can now spot adherence challenges before they compromise treatment plans. These sophisticated systems streamline the patient experience by personalizing side effect management, delivering proactive support through real-time monitoring, and creating adaptive intervention strategies that evolve with individual patient journeys. The key to a happy marriage with prime cardiometabolic health isn’t just the medication, it's the tech ecosystem keeping patients committed.

Featured:

The Future of Value-Based Care: Scaling Beyond Pilots

AI in Healthcare: From Hype to Practical Impact

Featured:

The Art of the Possible: Redefining Healthcare with Agentic AI

New State Consumer Data Privacy Laws: Implications for Life Sciences and Medical Device Companies

Featured:

Real-time conversations with other healthcare innovators!

Build your network by connecting with other healthcare leaders.

Featured:

AI Is Causing a Mental Health Revolution—So Why Is it Failing Women?

From Bias to Breakthrough: Revolutionizing Rare Disease Diagnosis and Treatment for Women

HLTH 2025

Clinicians @ HLTH Series: Physicians of the Future: The Evolving Doctor Persona In an Era of Innovation

CTRL + ALT + CARE: Delivering Health That Works — Trusted, Proven, Connected

Global Health Connector – Joining Dots, Transforming Lives!

Affordability Isn’t an Option—It’s the Key to Survival!

The Bigger Picture: Scaling Personalized Medicine for All

KLAS Bridging the Divide: Payer Intelligence and Collaborations that Speed Care

The Hinge Moment: Artificial Intelligence, Human Data, and Drug Development in the 21st Century

Seamless Operations = Better Patient Experience

Clinicians @ HLTH Series: Primary Care Reimagined: Powering the Future of Health

Transformation at the UK's National Health Service

From Research to Reality: Innovations Revolutionizing Oncology

Redefining Value Through Clinician-Led Care Models

The Future of Direct-to-Patient Success: Lessons Learned From Pioneers

Koalas, Kangaroos & Connected Health: Why Australian Innovation Should Be On Your Radar

The Weight on Her Shoulders: Women’s Mental Health

Caregiver Tech Support

Longevity Wonder Drugs

Prioritizing AI investments: Balancing Cost, Impact, and Innovation

From Access to Innovation: The Future of Primary Care in Community Health Centers

Buy Now, Weigh Less Later

Women are not Octopuses

The Golden Wave

The Latin America Innovation Summit

Better Data, Better Care: Enhancing Quality and Usability of Patient Data

Less Clicking, More Caring: Ambient AI and the New Era of Documentation

Women Have Heart